Atara Biotherapeutics, Inc. short interest in 2022
In 2022, Atara Biotherapeutics, Inc.'s disclosed short interest ran from 6.72% of shares outstanding on 14 Jan 2022 to 13.71% on 30 Dec 2022, a change of +6.99 percentage points. The year's high was 13.71% on 30 Dec 2022 and its low 6.72% on 14 Jan 2022, averaging 11.34% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.30 days on 29 Apr 2022. Full history: Atara Biotherapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 6.72% (14 Jan 2022)
- End of year
- 13.71% (30 Dec 2022)
- Change
- +6.99 pp
- High
- 13.71% (30 Dec 2022)
- Low
- 6.72% (14 Jan 2022)
- Average
- 11.34%
- Highest days to cover
- 14.30 (29 Apr 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 6.72% | 6.46 | |
| 31 Jan 2022 | 7.88% | 6.85 | results (8-K) |
| 15 Feb 2022 | 7.99% | 10.46 | |
| 28 Feb 2022 | 8.20% | 8.93 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 9.88% | 6.47 | |
| 31 Mar 2022 | 11.00% | 8.92 | |
| 14 Apr 2022 | 12.57% | 11.06 | |
| 29 Apr 2022 | 12.63% | 14.30 | |
| 13 May 2022 | 11.80% | 9.05 | 10-Q filed, results (8-K) |
| 31 May 2022 | 12.56% | 9.96 | |
| 15 Jun 2022 | 12.07% | 10.71 | |
| 30 Jun 2022 | 11.46% | 6.65 | |
| 15 Jul 2022 | 8.61% | 2.43 | |
| 29 Jul 2022 | 11.17% | 3.17 | |
| 15 Aug 2022 | 11.95% | 2.83 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 11.88% | 6.88 | |
| 15 Sep 2022 | 13.08% | 6.79 | |
| 30 Sep 2022 | 13.05% | 5.93 | |
| 14 Oct 2022 | 12.61% | 9.71 | |
| 31 Oct 2022 | 12.63% | 9.66 | |
| 15 Nov 2022 | 12.70% | 7.58 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 12.91% | 11.95 | |
| 15 Dec 2022 | 13.06% | 8.94 | |
| 30 Dec 2022 | 13.71% | 5.97 |
See also: Atara Biotherapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.